BHCFX
Baron Health Care Fund Retail Shares
1W: -2.5%
1M: -2.0%
3M: -0.1%
YTD: +6.2%
1Y: +17.8%
3Y: +27.3%
5Y: +1.6%
$22.23
+0.02 (+0.09%)
Weekly Expected Move ±2.0%
$21
$22
$22
$23
$23
ETF-Level Metrics
AUM$118M
Holdings39
Top 10 Wt43.4%
Beta0.58
% Profitable51%
Coverage86%
Portfolio Valuation
P/E29.2
P/B8.9
P/S6.8
EV/EBITDA23.0
P/FCF33.2
PEG0.92
Profitability & Returns
Gross Margin74.7%
Net Margin21.5%
ROE31.1%
ROA11.3%
ROIC20.2%
Div Yield0.57%
Leverage & Liquidity
Debt/Equity0.91
Debt/Assets0.33
Net Debt/EBITDA1.3x
Interest Cov18.9x
Current Ratio1.32
Quick Ratio1.00
Growth (YoY)
Revenue+36.4%
Net Income+22.4%
EPS+25.8%
FCF+40.8%
EBITDA+36.6%
Rev CAGR 3Y+37.1%
Quality Scores
Piotroski F5.6
Altman Z21.40
IS Quality64.4
IS Overall53.6
IS Value36.0
Median P/E24.5
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 38 | 88.5% | 6.8 |
| Other | 2 | 4.3% | — |
| Real Estate | 1 | 2.1% | 118.1 |
Smart Money Overlap
1 holdings with signals| Symbol | Company | Weight % | Signals | Badge | Insider Buys | Congress | Since Signal |
|---|---|---|---|---|---|---|---|
| PODD | Insulet Corp. | 1.40% | 4 | Bullish | 2 | 2 | -11.1% |
Showing 41 of 41 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | LLY.SW | 9.95% | $12.0M | 13,000 | 38.2 | $851.6B | Healthcare |
| 2 | AstraZeneca PLC | ZEG.DE | 5.09% | $6.1M | 31,000 | 23.4 | $249.2B | Healthcare |
| 3 | Johnson & Johnson | JNJ.SW | 4.58% | $5.5M | 22,500 | 29.6 | $535.1B | Healthcare |
| 4 | Thermo Fisher Scientific Inc | TN8.DE | 4.25% | $5.1M | 10,400 | 35.2 | $214.6B | Healthcare |
| 5 | Mettler-Toledo International Inc | MER.SW | 3.99% | $4.8M | 3,800 | — | $54.4B | Healthcare |
| 6 | Gilead Sciences Inc | GILD.SW | 3.48% | $4.2M | 30,000 | -55.7 | $143.2B | Healthcare |
| 7 | Teva Pharmaceutical Industries Ltd Private | — | 3.26% | $3.9M | 130,000 | — | — | — |
| 8 | Intuitive Surgical Inc | 0R29.L | 3.22% | $3.9M | 8,400 | 44.3 | $140.2B | Healthcare |
| 9 | Argenx SE | ARGNF | 3.16% | $3.8M | 5,200 | 33.3 | $58.2B | Healthcare |
| 10 | Roivant Sciences Ltd | ROIVW | 2.88% | $3.5M | 125,000 | -4.3 | $2.0B | Healthcare |
| 11 | Elanco Animal Health Inc | 5EA.DE | 2.84% | $3.4M | 142,500 | -54.0 | $10.0B | Healthcare |
| 12 | Ionis Pharmaceuticals Inc | 0JDI.L | 2.81% | $3.4M | 45,000 | -12.6 | $7.1B | Healthcare |
| 13 | RadNet Inc | RDNT | 2.79% | $3.4M | 60,000 | -262.4 | $5.5B | Healthcare |
| 14 | Vertex Pharmaceuticals Inc | VX1.DE | 2.79% | $3.3M | 7,500 | 29.1 | $113.3B | Healthcare |
| 15 | Insmed Inc | 0JAV.L | 2.72% | $3.3M | 20,000 | -27.0 | $23.7B | Healthcare |
| 16 | Merck & Co Inc | 6MK.DE | 2.50% | $3.0M | 25,000 | 114.5 | $314.9B | Healthcare |
| 17 | Guardant Health Inc | GH | 2.46% | $3.0M | 32,000 | -50.9 | $23.9B | Healthcare |
| 18 | Natera Inc | NTRA | 2.45% | $2.9M | 14,700 | -301.7 | $58.8B | Healthcare |
| 19 | Madrigal Pharmaceuticals Inc | MDGL | 2.31% | $2.8M | 5,300 | -38.7 | $11.5B | Healthcare |
| 20 | Edwards Lifesciences Corp | EW | 2.22% | $2.7M | 33,300 | 48.9 | $49.0B | Healthcare |
| 21 | IDEXX Laboratories Inc | 0J8P.L | 2.20% | $2.6M | 4,700 | 36.4 | $40.9B | Healthcare |
| 22 | Welltower Inc | 0LUS.L | 2.14% | $2.6M | 13,000 | 118.1 | $164.4B | Real Estate |
| 23 | Billiontoone Inc | BLLN | 1.77% | $2.1M | 27,000 | 153.5 | $4.9B | Healthcare |
| 24 | Terns Pharmaceuticals Inc | TERN | 1.54% | $1.8M | 35,000 | -51.4 | $4.8B | Healthcare |
| 25 | Stryker Corp | 0R2S.L | 1.50% | $1.8M | 5,500 | 28.3 | $103.0B | Healthcare |
| 26 | AbbVie Inc | 4AB.DE | 1.45% | $1.7M | 8,000 | 74.0 | $408.1B | Healthcare |
| 27 | Arcutis Biotherapeutics Inc | ARQT | 1.43% | $1.7M | 73,000 | 113.9 | $3.1B | Healthcare |
| 28 | Insulet Corp | PODD | 1.40% | $1.7M | 8,000 | 24.6 | $9.1B | Healthcare |
| 29 | Kymera Therapeutics Inc | KYMR | 1.39% | $1.7M | 20,000 | -33.0 | $8.8B | Healthcare |
| 30 | Protagonist Therapeutics Inc | PTGX | 1.32% | $1.6M | 15,000 | 115.0 | $9.0B | Healthcare |
| 31 | Cytokinetics Inc | CYTK | 1.26% | $1.5M | 23,000 | -9.1 | $8.2B | Healthcare |
| 32 | Xenon Pharmaceuticals Inc | XENE | 1.21% | $1.5M | 25,000 | -8.0 | $3.7B | Healthcare |
| 33 | Ascendis Pharma A/S Private | — | 1.07% | $1.3M | 5,600 | — | — | — |
| 34 | Apogee Therapeutics Inc | APGE | 1.05% | $1.3M | 15,000 | -31.1 | $8.4B | Healthcare |
| 35 | HeartFlow Inc | HTFL | 0.99% | $1.2M | 48,848 | -34.7 | $4.3B | Healthcare |
| 36 | Repligen Corp | RGEN | 0.88% | $1.1M | 9,000 | 245.5 | $10.3B | Healthcare |
| 37 | Dexcom Inc | DXCM | 0.84% | $1.0M | 16,000 | 33.0 | $32.2B | Healthcare |
| 38 | VeraDermics Inc | MANE | 0.53% | $631,500 | 10,000 | — | $4.9B | Healthcare |
| 39 | Medline Inc | MDLN | 0.52% | $623,000 | 14,000 | 41.4 | $30.1B | Healthcare |
| 40 | Abivax SA | ABVX | 0.51% | $612,425 | 5,500 | -17.7 | $6.8B | Healthcare |
| 41 | Revolution Medicines Inc | RVMD | 0.20% | $243,125 | 2,500 | -23.3 | $43.9B | Healthcare |